Related Experiment Video
Updated: May 5, 2026

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
Published on: September 28, 2018
Circular Approach to Biomanufacturing: Enhancing Therapeutic Protein Production Using Chum Salmon Head Peptone
Svini Dileepa Marasinghe1,2, Minthari Sakethanika Bandara1,2, Somyong Lee3
1Jeju Bio Research Center, Korea Institute of Ocean Science and Technology, 2670, Iljudong-ro, Gujwa-eup, Jeju 63349, Republic of Korea.
Abstract:
Fish waste disposal poses significant environmental and economic challenges, limiting sustainability in the marine food industry. Hence, sustainable valorization strategies are needed to enhance resource recovery while minimizing waste. As an approach, this study aimed to evaluate the potential of converting chum salmon (Oncorhynchus keta) head (CSH) waste into a high-value peptone for microbiological applications. Various proteolytic enzymes were screened for CSH hydrolysis, among which Protamex achieved the highest hydrolysis and recovery rates. The resulting chum salmon head peptone (CSHP) exhibited favorable characteristics, including a low average molecular mass (557 Da) and a high amino nitrogen content (4.9%), outperforming commercial animal (AP) and vegetable (VP) peptones. To assess its biotechnological potential, CSHP was evaluated as a nitrogen source for recombinant protein production and supported higher expression of human superoxide dismutase (hSOD) and human growth hormone (hGH) in Escherichia coli BL21(DE3), compared with AP, VP, and Luria-Bertani (LB) media. Furthermore, life cycle assessment revealed a substantially lower carbon footprint for CSHP production than that of conventional peptone sources. These findings suggest that CSHP is a reliable and sustainable alternative to traditional peptones, offering both therapeutic and industrial applications while contributing to marine waste reduction and circular bioeconomy strategies.
More Related Videos
06:24Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Related Concept Videos
Upstream Processing
Production of Antibiotics
Bioreactor Controls-III
Production of Pharmaceuticals